Vassilios James Bezzerides, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tachycardia, Supraventricular | 4 | 2020 | 223 | 1.690 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2020 | 2134 | 1.540 |
Why?
|
| Wolff-Parkinson-White Syndrome | 2 | 2019 | 102 | 1.410 |
Why?
|
| Myocytes, Cardiac | 13 | 2020 | 1589 | 1.350 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2021 | 184 | 1.140 |
Why?
|
| Tachycardia, Ventricular | 6 | 2020 | 1160 | 1.000 |
Why?
|
| Ventricular Fibrillation | 2 | 2021 | 552 | 0.870 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2019 | 21 | 0.790 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2020 | 592 | 0.770 |
Why?
|
| Personnel Selection | 1 | 2020 | 197 | 0.700 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2020 | 453 | 0.700 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2020 | 1532 | 0.630 |
Why?
|
| Electrocardiography | 7 | 2020 | 6435 | 0.600 |
Why?
|
| Research Personnel | 1 | 2020 | 496 | 0.600 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2017 | 340 | 0.590 |
Why?
|
| Action Potentials | 4 | 2020 | 1846 | 0.560 |
Why?
|
| Heart Defects, Congenital | 3 | 2020 | 4132 | 0.540 |
Why?
|
| Immediate-Early Proteins | 1 | 2017 | 465 | 0.530 |
Why?
|
| Career Choice | 1 | 2020 | 722 | 0.530 |
Why?
|
| Models, Cardiovascular | 2 | 2016 | 1033 | 0.520 |
Why?
|
| Physical Conditioning, Animal | 2 | 2015 | 365 | 0.460 |
Why?
|
| Nitroso Compounds | 1 | 2011 | 69 | 0.450 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2011 | 65 | 0.450 |
Why?
|
| Nitrites | 1 | 2011 | 165 | 0.440 |
Why?
|
| Thromboembolism | 1 | 2017 | 988 | 0.440 |
Why?
|
| Barth Syndrome | 2 | 2021 | 21 | 0.430 |
Why?
|
| Catheter Ablation | 2 | 2020 | 2311 | 0.390 |
Why?
|
| Heart Rate | 2 | 2020 | 4180 | 0.390 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2011 | 487 | 0.340 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 2152 | 0.340 |
Why?
|
| Atrial Fibrillation | 2 | 2021 | 4038 | 0.330 |
Why?
|
| Biomedical Research | 1 | 2020 | 3285 | 0.270 |
Why?
|
| Transport Vesicles | 1 | 2004 | 89 | 0.270 |
Why?
|
| Nitric Oxide | 1 | 2011 | 2054 | 0.240 |
Why?
|
| Heart Conduction System | 2 | 2018 | 1066 | 0.230 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 2091 | 0.220 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2020 | 42 | 0.210 |
Why?
|
| Sotalol | 1 | 2020 | 46 | 0.210 |
Why?
|
| Calcium Channels | 1 | 2004 | 654 | 0.200 |
Why?
|
| Heart Rate, Fetal | 1 | 2020 | 74 | 0.200 |
Why?
|
| Telemetry | 1 | 2020 | 204 | 0.190 |
Why?
|
| Naphthyridines | 1 | 2019 | 124 | 0.190 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 314 | 0.190 |
Why?
|
| Channelopathies | 1 | 2018 | 26 | 0.190 |
Why?
|
| Cells, Cultured | 8 | 2020 | 20620 | 0.180 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2020 | 743 | 0.180 |
Why?
|
| Activin Receptors, Type II | 1 | 2019 | 116 | 0.180 |
Why?
|
| Fetal Heart | 1 | 2020 | 265 | 0.180 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2018 | 75 | 0.180 |
Why?
|
| Animals, Newborn | 3 | 2019 | 2950 | 0.170 |
Why?
|
| Death, Sudden | 1 | 2018 | 302 | 0.160 |
Why?
|
| Injections, Subcutaneous | 1 | 2017 | 694 | 0.160 |
Why?
|
| Mitochondria, Heart | 1 | 2017 | 246 | 0.150 |
Why?
|
| Retrospective Studies | 10 | 2020 | 67320 | 0.150 |
Why?
|
| Bundle-Branch Block | 1 | 2018 | 279 | 0.150 |
Why?
|
| Myocardium | 2 | 2020 | 5024 | 0.150 |
Why?
|
| S100 Proteins | 1 | 2016 | 275 | 0.150 |
Why?
|
| Syncope | 1 | 2019 | 438 | 0.150 |
Why?
|
| Radio Waves | 1 | 2016 | 240 | 0.150 |
Why?
|
| Adolescent | 12 | 2020 | 84957 | 0.140 |
Why?
|
| Bandages | 1 | 2016 | 248 | 0.140 |
Why?
|
| STAT1 Transcription Factor | 1 | 2016 | 354 | 0.140 |
Why?
|
| Exercise | 1 | 2011 | 5078 | 0.140 |
Why?
|
| Fetal Diseases | 1 | 2020 | 860 | 0.140 |
Why?
|
| Dependovirus | 1 | 2020 | 706 | 0.140 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15083 | 0.140 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 1443 | 0.140 |
Why?
|
| Adenoviridae | 1 | 2019 | 1165 | 0.140 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 1237 | 0.140 |
Why?
|
| Humans | 32 | 2021 | 686663 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2020 | 869 | 0.130 |
Why?
|
| Animals | 15 | 2021 | 170849 | 0.130 |
Why?
|
| Long QT Syndrome | 1 | 2017 | 403 | 0.130 |
Why?
|
| Cell Proliferation | 4 | 2017 | 10990 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2020 | 2103 | 0.130 |
Why?
|
| Postoperative Care | 1 | 2020 | 1564 | 0.130 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2018 | 490 | 0.120 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 660 | 0.120 |
Why?
|
| Fontan Procedure | 1 | 2018 | 741 | 0.120 |
Why?
|
| Infusions, Intravenous | 1 | 2017 | 2334 | 0.120 |
Why?
|
| Heart | 2 | 2016 | 4233 | 0.120 |
Why?
|
| Foreign Bodies | 1 | 2016 | 390 | 0.120 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 908 | 0.120 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2020 | 1130 | 0.120 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2016 | 884 | 0.120 |
Why?
|
| Child, Preschool | 9 | 2020 | 41159 | 0.120 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 1251 | 0.110 |
Why?
|
| Heart Ventricles | 3 | 2019 | 3857 | 0.110 |
Why?
|
| Sports | 1 | 2017 | 652 | 0.110 |
Why?
|
| Pacemaker, Artificial | 1 | 2016 | 774 | 0.110 |
Why?
|
| Child | 10 | 2020 | 71361 | 0.110 |
Why?
|
| Prostheses and Implants | 1 | 2019 | 1304 | 0.110 |
Why?
|
| Heart Arrest | 1 | 2020 | 1306 | 0.110 |
Why?
|
| Male | 19 | 2020 | 352465 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2020 | 1778 | 0.110 |
Why?
|
| Cardiomegaly | 1 | 2014 | 637 | 0.100 |
Why?
|
| Mice, Knockout | 5 | 2021 | 15597 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2020 | 2570 | 0.100 |
Why?
|
| Phenotype | 4 | 2020 | 16091 | 0.100 |
Why?
|
| Heart Failure | 4 | 2020 | 9179 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 1747 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2777 | 0.100 |
Why?
|
| Cardiology | 1 | 2020 | 1625 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 10094 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 2912 | 0.090 |
Why?
|
| Signal Transduction | 6 | 2020 | 24351 | 0.090 |
Why?
|
| Tissue Engineering | 1 | 2019 | 1878 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 18495 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2020 | 11910 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 712 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 2253 | 0.090 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 1086 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2017 | 4807 | 0.090 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 3076 | 0.090 |
Why?
|
| Calcium | 1 | 2021 | 5696 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 2099 | 0.090 |
Why?
|
| Female | 15 | 2020 | 375459 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2016 | 3066 | 0.080 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 3471 | 0.080 |
Why?
|
| Mice | 7 | 2021 | 80803 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2645 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 1696 | 0.080 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2019 | 130 | 0.080 |
Why?
|
| Length of Stay | 1 | 2020 | 6241 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2020 | 5257 | 0.080 |
Why?
|
| Infant | 4 | 2020 | 33918 | 0.080 |
Why?
|
| Zebrafish | 1 | 2017 | 2969 | 0.070 |
Why?
|
| Incidence | 3 | 2020 | 20496 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 3006 | 0.070 |
Why?
|
| Pediatrics | 1 | 2020 | 3572 | 0.070 |
Why?
|
| Chromones | 1 | 2004 | 175 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2011 | 3969 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 11616 | 0.070 |
Why?
|
| Massachusetts | 1 | 2017 | 8920 | 0.070 |
Why?
|
| TRPC Cation Channels | 1 | 2004 | 128 | 0.070 |
Why?
|
| Electric Conductivity | 1 | 2004 | 445 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2020 | 23953 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 2103 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2016 | 3196 | 0.060 |
Why?
|
| MicroRNAs | 2 | 2020 | 3587 | 0.060 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2004 | 252 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2004 | 3982 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 13603 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2019 | 6772 | 0.060 |
Why?
|
| Androstadienes | 1 | 2004 | 346 | 0.060 |
Why?
|
| Aging | 2 | 2019 | 8222 | 0.060 |
Why?
|
| Exocytosis | 1 | 2004 | 379 | 0.060 |
Why?
|
| Time Factors | 5 | 2020 | 42271 | 0.060 |
Why?
|
| Neurites | 1 | 2004 | 386 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2017 | 4173 | 0.060 |
Why?
|
| Cell Line | 3 | 2020 | 17137 | 0.060 |
Why?
|
| Cation Transport Proteins | 1 | 2004 | 322 | 0.060 |
Why?
|
| Young Adult | 5 | 2020 | 56052 | 0.060 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 206 | 0.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2004 | 451 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 3365 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 994 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 39737 | 0.060 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3223 | 0.060 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3344 | 0.060 |
Why?
|
| Pandemics | 1 | 2020 | 5859 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 17071 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 749 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 911 | 0.050 |
Why?
|
| Morpholines | 1 | 2004 | 594 | 0.050 |
Why?
|
| Echocardiography | 3 | 2020 | 5097 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21684 | 0.050 |
Why?
|
| Toluene | 1 | 2019 | 40 | 0.050 |
Why?
|
| Adult | 8 | 2020 | 211400 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5252 | 0.050 |
Why?
|
| Rats | 4 | 2020 | 25307 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2020 | 60991 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 12680 | 0.050 |
Why?
|
| Follistatin-Related Proteins | 1 | 2019 | 55 | 0.050 |
Why?
|
| Desmoplakins | 1 | 2019 | 70 | 0.050 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2019 | 97 | 0.050 |
Why?
|
| Benzothiazoles | 1 | 2019 | 252 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2003 | 955 | 0.050 |
Why?
|
| Fetal Death | 1 | 2020 | 458 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 2238 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2014 | 13469 | 0.040 |
Why?
|
| Activins | 1 | 2019 | 233 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2003 | 1334 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2020 | 488 | 0.040 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2016 | 39 | 0.040 |
Why?
|
| Protein Transport | 1 | 2003 | 2101 | 0.040 |
Why?
|
| Heart Block | 1 | 2018 | 418 | 0.040 |
Why?
|
| Genetic Testing | 2 | 2020 | 3230 | 0.040 |
Why?
|
| Systole | 1 | 2019 | 1008 | 0.040 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2016 | 72 | 0.040 |
Why?
|
| Mutation | 2 | 2020 | 28848 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 981 | 0.040 |
Why?
|
| Kinetics | 1 | 2004 | 6979 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2004 | 5678 | 0.040 |
Why?
|
| Cell Enlargement | 1 | 2015 | 56 | 0.040 |
Why?
|
| Pressure | 1 | 2019 | 1235 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2020 | 1915 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2016 | 443 | 0.040 |
Why?
|
| Protein Stability | 1 | 2016 | 563 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 2833 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 2334 | 0.030 |
Why?
|
| Heart Atria | 1 | 2020 | 1241 | 0.030 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2014 | 101 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 13413 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2014 | 96 | 0.030 |
Why?
|
| Vascular System Injuries | 1 | 2016 | 182 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 1140 | 0.030 |
Why?
|
| Fibrosis | 1 | 2020 | 1798 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 8707 | 0.030 |
Why?
|
| Neuregulin-1 | 1 | 2014 | 143 | 0.030 |
Why?
|
| Risk Factors | 4 | 2020 | 69278 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2016 | 991 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 293 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 2944 | 0.030 |
Why?
|
| Cell Shape | 1 | 2014 | 376 | 0.030 |
Why?
|
| Cell Communication | 1 | 2020 | 1658 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3998 | 0.030 |
Why?
|
| Imidazoles | 1 | 2019 | 1288 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2020 | 1531 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 2056 | 0.030 |
Why?
|
| Ligands | 1 | 2019 | 3189 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2019 | 1498 | 0.030 |
Why?
|
| Gestational Age | 1 | 2020 | 3308 | 0.030 |
Why?
|
| Hippocampus | 1 | 2004 | 3587 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 1774 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 23439 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2014 | 961 | 0.030 |
Why?
|
| Models, Biological | 2 | 2004 | 10102 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2016 | 1668 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2020 | 4345 | 0.020 |
Why?
|
| Kidney | 1 | 2004 | 6744 | 0.020 |
Why?
|
| Recurrence | 1 | 2020 | 8198 | 0.020 |
Why?
|
| Piperazines | 1 | 2019 | 2576 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9661 | 0.020 |
Why?
|
| Protein Binding | 2 | 2016 | 9947 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2020 | 23739 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1721 | 0.020 |
Why?
|
| Transfection | 1 | 2016 | 6329 | 0.020 |
Why?
|
| DNA Damage | 1 | 2017 | 2507 | 0.020 |
Why?
|
| RNA Interference | 1 | 2016 | 3103 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 3429 | 0.020 |
Why?
|
| Neurons | 1 | 2004 | 9331 | 0.020 |
Why?
|
| Boston | 1 | 2018 | 9534 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 14656 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15407 | 0.020 |
Why?
|
| Cholinergic Agonists | 1 | 2003 | 86 | 0.020 |
Why?
|
| Computational Biology | 1 | 2016 | 3612 | 0.020 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 100 | 0.020 |
Why?
|
| Diglycerides | 1 | 2003 | 180 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2003 | 142 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11833 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 4477 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 19295 | 0.010 |
Why?
|
| United States | 2 | 2020 | 65579 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 14744 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 12095 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 16227 | 0.010 |
Why?
|
| Hormones | 1 | 2003 | 777 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 28923 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 25703 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 9934 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1746 | 0.010 |
Why?
|
| Reaction Time | 1 | 2003 | 2115 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 4184 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3983 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59331 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 162271 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 216468 | 0.000 |
Why?
|